Blueprint Medicines Reports First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. QGEN
10. SPY

Go back to Blueprint Medicines Reports First Quarter 2020 Financial Results

Blueprint Medicines (BPMC) Tops Q1 EPS by 6c, Revenues Beat

May 6, 2020 7:19 AM EDT

Blueprint Medicines (NASDAQ: BPMC) reported Q1 EPS of ($2.11), $0.06 better than the analyst estimate of ($2.17). Revenue for the quarter came in at $6.16 million versus the consensus estimate of $5.44 million.

"Our progress in recent months is a testament to the agility of the Blueprint... More